Pharma Solutions

Piramal Pharma Solutions is the Contract Development and Manufacturing Organisation (CDMO) business under Piramal Pharma Limited (PPL), with operations in North America, Europe and Asia. A global leader in integrated solutions, it offers a comprehensive range of services across the drug lifecycle from drug discovery services and development to commercial manufacturing of drug substances and drug products. Leveraging its capabilities as an integrated service provider and experience with various cutting-edge technologies, enables Piramal Pharma Solutions effectively serves innovator and generic companies worldwide. With accreditations from regulatory bodies in the US, Europe & Japan, its development centres and manufacturing sites across the globe, have a pool of over 450 scientists, including 155 Ph.Ds. committed to research and development programs.

Piramal Pharma Solutions is committed towards translating your high potency discovery to commercial reality.

A ‘Customer Centric’ organization, Piramal Pharma Solutions has the “Pulse of the Customer” at the heart of its mission.

Awards and Accolades:

  • Awarded ‘Industry Partner of the Year 2018’ at the Global Generics & Biosimilars Awards at the recently held CPhI Conference
  • Received ‘Best Customer Experience Award of the Year – Pharmaceutical’ at Customer Fest 2016
Visit Website

Critical Care

1331 A leading producer of Inhaled Anesthetics and a global player in Hospital Generics, Piramal Critical Care is committed to saving lives by delivering critical care solutions for patients and healthcare providers across the globe.

Read More

Consumer Products

1333 Consumer Products Division (CPD), Piramal's Domestic Healthcare business division, caters to the Indian self-care market with its purpose to improve people's lives by addressing their routine-disruptors

Read More

Allergan India Private Limited

5818 Allergan India Private Limited, a joint venture between Allergan (now part of AbbVie) and Piramal Pharma Limited, commenced commercial operations in 1996.

Read More